dr bryan moyer - amgen
Published 4 years ago • 209 plays • Length 22:11Download video MP4
Download video MP3
Similar videos
-
2:30
microneedling: not just for your face
-
1:54
biosimilars are alternatives for original antibodies
-
0:20
viome precision supplements - made for your unique biological code.
-
1:55
updates in immunotherapy for multiple myeloma: bites & novel targets
-
7:30
mit2 overview
-
3:16
end stage multiple myeloma
-
12:26
treating ultra high risk myeloma patients in a unique uk study | martin kaiser, md | ash 2021
-
10:48
early treatment and novel therapeutic targets for multiple myeloma
-
1:13
dr. ralph kern explains how an imbalance of the immune system can cause damage to the cns
-
1:13
contour medical can help you lose the jowls!
-
8:41
novel management strategies for ms relapse
-
1:44
dr. schmid on challenges concerning biosimilars in oncology
-
2:12
sunny by shenb - latest monopolar rf device with 25 years of rf expertise
-
0:50
the expanding therapeutic landscape of r/r multiple myeloma
-
1:02
novel agents in multiple myeloma: considering toxicity and side effects
-
3:01
novel promising agents and clinical trials in amyloidosis
-
9:08
biological mechanisms of aml: a 2019 update
-
1:05
expanding multiple myeloma advances beyond the us and europe – an international initiative
-
2:25
addressing clinical trial misconceptions: the facts.
-
2:19
design of a phase i trial of eftozanermin alfa plus bortezomib and dex in r/r myeloma
-
4:27
monoclonal antibodies for multiple myeloma